Business

Akoustis Founder and CEO Jeff Shealy to Discuss the CHIPS and Science Act 2022 and 5G Mobile on Yahoo Finance at 11:40 am ET Today

Charlotte, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ : AKTS) (“Akoustis” or the “Company”), an integrated device

articleAktis Oncology, Inc.August 1, 20224/company/aktis-oncology-inc-common-stock/news/akoustis-founder-and-ceo-jeff-shealy-to-discuss-the-chips-and-science-act-2022-and-5g
Akoustis Founder and CEO Jeff Shealy to Discuss the CHIPS and Science Act 2022 and 5G Mobile on Yahoo Finance at 11:40 am ET Today

About this update from Aktis Oncology, Inc.

[{"type":"text","content":"Charlotte, N.C., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ : AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that founder and CEO Jeff Shealy is scheduled to be a guest on Yahoo Finance hosted by Brian Sozzi, Julie Hyman and Brad Smith today at 11:40 am ET. Interview Topics Include: The CHIPS and Science Act 20225G network rollouts worldwideThe global chip shortageAkoustis’ made-in-America XBAW® filters Akoustis is actively delivering volume production of its Wi-Fi 6 tandem filter solutions, shipping multiple 5G small cell XBAW® filter solutions, delivering initial designs of its new 5G mobile filter solutions to multiple customers and has entered the market with its new Wi-Fi 6E coexistence XBAW® filter solutions. To date, Akoustis has received more than 20 customer design wins for its patented XBAW® filter solutions. About Akoustis Technologies, Inc. Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The Company utilizes its proprietary and patented XBAW® manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, high-purity and single-crystal piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications. Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 120,000 sq. ft. ISO-9001:2015 registered commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility - tooled for 150-mm diameter wafers - for the design, dev...

More updates from Aktis Oncology, Inc.